PCR & NGS Based Diagnostic Testing Market Analysis

PCR & NGS Based Diagnostic Testing Market Analysis

The consumables segment in the PCR & NGS based diagnostic testing market accounted for USD 18.8 billion in 2020. Consumable segment includes the disposable products that are used in the PCR & NGS based diagnostic testing. This includes diagnostic kits (inclusive of COVID-19 detection kits), reagents, tips, plates, plastic cases etc. As these products are non-reusable, there is repetitive requirement of consumables in diagnostic tests. High demand and usage of consumables products is the prominent reason for its high industry size.

The diagnostic centers segment captured 36% of the PCR & NGS based diagnostic testing market share in 2020. The diagnostic centers are the special facilities with extensive variety of diagnostic testing procedures including PCR & NGS based diagnostic testing. Besides, the diagnostic centers have high testing capacity along with high accuracy due to advanced technology and apt medical infrastructure. All these factors are driving the segment growth for diagnostic centers in the short term. However, with reduction in COVID cases and tests, the market is expected to show negative growth by the end of the forecast period.

The U.S. dominated the North America PCR & NGS based diagnostic testing market and accounted for over USD 5.4 billion in 2020. Also, the North America market is projected to showcase 1.2% growth rate through 2027 owing to the rising sales of consumables such as test kits, sample collectors and equipment like thermal cyclers. There has been sudden rise in the number of diagnostic tests since the outbreak of a pandemic. Moreover, increase in the diagnostic centers, ambulatory settings and makeshift facilities during the pandemic has resulted in high demand for PCR & NGS based diagnostic testing equipment and consumable materials supporting the industry expansion. In addition, presence of major market players such as Qiagen, Agilent, and Thermo Fisher Scientific among others is aiding the growth of PCR and NGS based diagnostic testing market in the region.